Colorectal cancer Posts Page 2 on Medivizor
Navigation Menu

Colorectal cancer Posts on Medivizor

FOLFIRI plus aflibercept in the treatment of metastatic colorectal cancer outside of clinical trials

Posted by on Mar 29, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of the combined treatment FOLFIRI with aflibercept (Zaltrap) outside of clinical trials in patients with metastatic (spread to other parts of the body) colorectal cancer (mCRC). Researchers suggested that this treatment might be a safe second line option in patients who progressed after first-line...

Read More

Consolidation chemotherapy before surgery improves the outcomes in advanced rectal cancer.

Posted by on Mar 29, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of consolidation chemotherapy after initial treatment in locally advanced rectal cancer. Researchers suggested that this treatment is safe and is associated with improved cancer outcomes.  Some background Colorectal cancer is the fifth most common cancer. From all the colorectal...

Read More

X-ray brachytherapy might be a safer option in the treatment of early rectal cancers

Posted by on Mar 20, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effect of X-ray brachytherapy (XRB) in the treatment of patients with rectal cancer who underwent local surgery. Researchers suggested that XRB is associated with improved outcomes and could be used instead of radical surgery. Some background Screening programs increased the number of patients being diagnosed...

Read More

Stereotactic body radiotherapy improves survival of patients with metastatic colorectal cancer

Posted by on Mar 17, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of stereotactic body radiotherapy (SBRT) in metastatic (spread to other parts of the body) colorectal cancer outcomes. Researchers suggested that SBRT improves survival in these patients. Some background Colorectal cancer is the third most common cancer worldwide. The liver is the most...

Read More

Transanal endoscopic microsurgery after chemoradiotherapy improves rectal cancer outcomes

Posted by on Feb 28, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated long term rectal cancer outcomes in patients who received chemotherapy, radiation therapy, and transanal microsurgery. Researchers suggested that this treatment improves treatment outcomes and quality of life of patients. Some background The standard treatment for rectal cancer is surgery. However,...

Read More

Chemotherapy and radiation therapy are safe options before surgery in elderly patients with rectal cancer

Posted by on Feb 13, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of chemotherapy and radiation therapy (CRT) with capecitabine (Xeloda) before surgery in elderly patients with locally advanced rectal cancer. Researchers suggested that this treatment is safe and well tolerated in the elderly. Some background Colorectal cancer is the third most commonly...

Read More

Can CEA levels predict tumor response to treatment in advanced colorectal cancer?

Posted by on Feb 12, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the relationship between changes in the levels of carcinoembryonic antigen (CEA) and colorectal cancer response to treatment. Researchers suggested that CEA levels are associated with tumor response and can be used as a prognostic factor. Some background In 2014 the European Society for Medical Oncology...

Read More

A home-based exercise program improves the quality of life of colorectal cancer survivors

Posted by on Jan 31, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effects of home-based physical exercise (PE) on the quality of life of patients with colorectal cancer. Researchers suggested that this program may improve the mental health and quality of life of these patients. Some background Early diagnosis and new therapies have improved the survival rates of patients...

Read More

Regorafenib followed by cetuximab is associated with longer survival in the treatment of advanced colorectal cancer

Posted by on Jan 29, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of treatment with regorafenib (Stivarga) followed by cetuximab (Erbitux) in the treatment of advanced colorectal cancer. Researchers suggested that this treatment improves survival of these patients. Some background New treatments have become available in the past 20 years to treat...

Read More

Hypofractionated stereotactic radiotherapy improves outcomes in advanced colorectal cancer

Posted by on Jan 20, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of hypofractionated stereotactic radiotherapy (HSR; high doses of radiation given in fewer sessions than conventional radiotherapy) in advanced colorectal cancer. Researchers suggested that HSR is associated with improved outcomes and manageable side effects. Some background Colorectal cancer is...

Read More